后弹力层内皮角膜移植术后黄斑囊样水肿
该研究回顾了2019年1月至2020年3月在Rothschild基金会医院接受单纯DMEK或联合白内障手术(三联DMEK)的患者记录,排除术前OCT已存在CMO者。246眼中23眼(9.36%)发生临床显著CMO,PBK、ERM和术中前房积血与CMO发生相关。
要点
- DMEK术后临床显著CMO发生率为9.36%(23/246眼)。
- 三联DMEK与单纯DMEK的CMO风险无显著差异(12.2% vs 6.1%)。
- PBK、ERM和术中前房积血与术后CMO发生相关。
核心结论
- DMEK术后临床显著CMO发生率为9.35%。
- 有ERM、PBK病史及术中前房积血的患者DMEK术后可能处于发生CMO的风险中,应予以监测。
研究设计与样本
- 回顾性分析2019年1月至2020年3月在Rothschild基金会医院(法国巴黎)接受单纯DMEK或三联DMEK手术患者的记录。
- 排除术前黄斑OCT已存在CMO的患者,对术后视力损害者行谱域OCT检查。
- 收集并分析合并症、术中特征及术后治疗或并发症数据,进行单变量和多变量分析。
主要发现
- 246眼中23眼(9.36%)发生临床显著CMO。
- 单纯DMEK组CMO发生率为12.2%,三联DMEK组为6.1%,三联DMEK与CMO风险升高无关联。
- 发生CMO的患者中PBK更常见(39.1% vs 9%;OR=3.5(1.0至11.8),p=0.045)。
- 发生CMO的患者中ERM更常见(39.1% vs 7.7%;OR=10.5(3.4至32.3),p<0.001)。
- 术中前房积血与术后CMO有统计学关联(13% vs 1.3%;OR=7.1(1.0至48.8),p=0.045)。
关键数值与推荐
- CMO发生率9.36%(23/246眼)。
- PBK:39.1% vs 9%;OR=3.5(1.0至11.8),p=0.045。
- ERM:39.1% vs 7.7%;OR=10.5(3.4至32.3),p<0.001。
- 术中前房积血:13% vs 1.3%;OR=7.1(1.0至48.8),p=0.045。
- 术中上皮刮除:65.2% vs 33.2%,p=0.005(仅单变量分析)。
临床怎么用
- 有ERM、PBK病史及术中前房积血的患者DMEK术后可能处于发生CMO的风险中,应予以监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine the incidence and risk factors of cystoid macular oedema (CMO) following descemet membrane endothelial keratoplasty (DMEK) with or without combined cataract surgery (triple-DMEK). METHODS: We reviewed the records of patients who underwent DMEK surgery alone or triple-DMEK performed at the Rothschild Foundation Hospital (Paris, France) between January 2019 and March 2020. Patients with pre-existing CMO observed on the preoperative macular optical coherence tomography (OCT) were excluded. Spectral-domain OCT was performed in patients with postoperative visual impairment. Data regarding comorbidities, intraoperative characteristics and postoperative treatments or complications were collected and analysed. Univariate and multivariate analyses were performed. RESULTS: Twenty three of 246 eyes (9.36%) developed clinically significant (cs)-CMO after DMEK. Triple-DMEK was not associated with a higher risk to develop CMO (12.2% in DMEK alone and 6.1% in triple-DMEK). Pseudophakic bullous keratopathy (PBK ; 39.1% vs 9%; OR=3.5 (1.0 to 11.8), p=0.045) and epiretinal membrane (ERM; 39.1% vs 7.7%; OR=10.5 (3.4 to 32.3), p<0.001) were more frequently observed in patients who developed CMO. The occurrence of hyphaema during surgery was statistically associated with postoperative CMO (13% vs 1.3%; OR=7.1 (1.0 to 48.8) p=0.045). Peroperative epithelial debridement was statistically associated with postoperative CMO (65.2% vs 33.2%, p=0.005), but only in univariate analysis. CONCLUSIONS: We identified a clinically significant CMO incidence of 9.35% after DMEK. Patients with a history of ERM, PBK and intraoperative hyphaema may be at risk of developing CMO after DMEK surgery and should be monitored.
引用
- Guindolet D, Huynh O, Martin GC, et al. Cystoid macular oedema after descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2021. PMID: 34750101. doi:10.1136/bjophthalmol-2021-319455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。